Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-Aminopyridine in Carpal Tunnel Syndrome
NCT06294821Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in carpal tunnel syndrome (CTS) comparing 4-aminopyridine with Placebo (2 arms). Primary endpoints: Boston Carpal Tunnel Syndrome Questionnaire and Michigan Hand Outcomes Questionnaire. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dalfampridine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06294821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06294821.